Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000919574-26-001077·EUPRAXIA PHARMACEUTICALS INC.
Schedule 13G ownership disclosure
EUPRAXIA PHARMACEUTICALS INC
Common Shares · CUSIP: 29842P105
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- MANCHESTER MANAGEMENT COMPANY, LLC
Shares: 4,720,144.00 · Class: 8.8%
- MANCHESTER MANAGEMENT PR, LLC
Shares: 4,720,144.00 · Class: 8.8%
- MANCHESTER EXPLORER, L.P
Shares: 4,597,217.00 · Class: 8.6%
- JAMES E. BESSER
Shares: 4,858,437.00 · Class: 9.1%
- MORGAN C. FRANK
Shares: 4,904,523.00 · Class: 9.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-26-001077
- Form type
- SCHEDULE 13G/A
- Filer
- EUPRAXIA PHARMACEUTICALS INC.
- CIK
- CIK 1581178
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership